Home > News > Warburg Research reiterates Nanostart's buy rating
January 21st, 2011
Warburg Research reiterates Nanostart's buy rating
Abstract:
Nanotechnology investor Nanostart (OTCQX: NNS, NASRY) had its 'buy' rating reiterated by equity research firm Warburg Research on Friday, following Nanostart's recent sale and acquisition of various company interests.
Venture investor Nanostart, through its Singapore-based early stage fund, recently sold its stake in Curiox, which it acquired in 2007, earlier than originally expected. According to Nanostart, a small profit was made from the deal, which will flow back into the fund's assets, and will therefore not be distributed as dividends or have a corresponding impact on earnings, said Warburg.
Source:
proactiveinvestors.com
Bookmark:
| Related News Press |
News and information
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||